Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Qingkailing Injection on Corticosteroids Withdrawal Rate in Patients With Active Rheumatoid Arthritis

NCT02264301 is registered in ClinicalTrials.gov with Chengdu PLA General Hospital as lead sponsor.

NCT NCT02264301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02264301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Qingkailing Injection on Corticosteroids Withdrawal Rate in Patients With Active Rheumatoid Arthritis
Lead sponsor
Chengdu PLA General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2014
Completion date
December 31, 2017
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis